Simplex Trading’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-32,200
| Closed | -$179K | – | 11951 |
|
|
2021
Q3 | $179K | Sell |
32,200
-6,800
| -17% | -$33K | ﹤0.01% | 5779 |
|
|
2021
Q2 | $205K | Buy |
39,000
+38,912
| +44,218% | +$201K | ﹤0.01% | 5649 |
|
|
2021
Q1 | $42K | Buy |
88
+76
| +633% | +$397 | ﹤0.01% | 6821 |
|
|
2020
Q4 | $5K | Buy |
12
+7
| +140% | +$30 | ﹤0.01% | 7759 |
|
|
2020
Q3 | $2K | Buy |
+5
| New | +$19 | ﹤0.01% | 7490 |
|
|
2020
Q2 | – | Sell |
-11
| Closed | -$3K | – | 8692 |
|
|
2020
Q1 | $3K | Sell |
11
-29
| -73% | -$130 | ﹤0.01% | 7130 |
|
|
2019
Q4 | $15K | Sell |
40
-37
| -48% | -$177 | ﹤0.01% | 6171 |
|
|
2019
Q3 | $39K | Buy |
77
+73
| +1,825% | +$451 | ﹤0.01% | 5263 |
|
|
2019
Q2 | $2K | Buy |
4
+2
| +100% | +$12 | ﹤0.01% | 6811 |
|
|
2019
Q1 | $1K | Sell |
2
-262
| -99% | -$2.36K | ﹤0.01% | 6991 |
|
|
2018
Q4 | $225K | Sell |
264
-15
| -5% | -$195 | ﹤0.01% | 3038 |
|
|
2018
Q3 | $558K | Sell |
279
-14
| -5% | -$329 | ﹤0.01% | 2516 |
|
|
2018
Q2 | $756K | Sell |
293
-20
| -6% | -$554 | ﹤0.01% | 2040 |
|
|
2018
Q1 | $31K | Buy |
313
+178
| +132% | +$5.61K | ﹤0.01% | 2923 |
|
|
2017
Q4 | $85K | Buy |
+135
| New | +$3.77K | ﹤0.01% | 1935 |
|
|
2016
Q1 | – | Sell |
-25
| Closed | -$35K | – | 6512 |
|
|
2015
Q4 | $35K | Buy |
+25
| New | +$421 | ﹤0.01% | 2217 |
|
Simplex Trading's ADMS Position: Q2 2021 in Review
Simplex Trading sold out of Adamas Pharmaceuticals (ADMS) in Q2 2021, closing a stake of 3,236 shares — an estimated $16.7K sold.
Simplex Trading first reported a position in ADMS in Q4 2015 and held it in 14 quarters. The position peaked at $762K in Q3 2017. 67 funds tracked by Wall St. Rank hold ADMS as of Q2 2021.
- Simplex Trading reported no remaining Adamas Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Simplex Trading sold 3,236 Adamas Pharmaceuticals shares in Q2 2021, an estimated $16.7K.
- Simplex Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 14 quarters.
- Simplex Trading's Adamas Pharmaceuticals position peaked at $762K in Q3 2017.
- 67 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2021.
Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.